查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1712793

2025年植入式生医材料全球市场报告

Implantable Biomaterials Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年可植入生医材料市场规模将强劲成长。到 2029 年，这一数字将成长至 2,399.2 亿美元，复合年增长率为 9.7%。预测期内的成长归因于生物活性和生物可吸收材料、智慧和响应性生物材料、法规和安全标准、混合复合材料和组织工程的进步。预测期内的关键趋势包括药物释放型植入、生物相容性的进步、3D 列印和客製化、再生医学的关注以及奈米技术的整合。

政府对新生医材料进步的投资是植入式生医材料市场成长的主要驱动力，例如美国科学基金会向德雷塞尔大学津贴2,000 万美元等计划。这项资金支持将促进对生医材料介导的巨噬细胞行为控制以及生医材料对血管生成的影响的研究。政府机构的支持将推动植入式生医材料的进一步发展。

心血管疾病患者数量的增加预计将推动植入式生医材料市场的成长。心血管疾病包括影响心臟和血管的各种疾病。随着心血管疾病发病率的上升，对这些疾病的治疗和管理至关重要的可植入生医材料的需求也在增加。这些材料用于各种医疗设备和程序来修復或替换受损的心血管组织。随着越来越多的人面临心血管问题，对有效和创新的生医材料的需求也日益增长，最终将导致开发更好、更有效的植入，以改善患者的治疗效果和生活品质。例如，总部位于瑞士的非政府组织世界心臟联盟于2022年10月发布的报告预测，到2050年，死于心血管疾病的人数将从2,220万人增加到3,230万人。因此，心血管疾病患者的增加预计将推动可植入生物材料市场向前发展。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式生医材料PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球植入式生医材料市场：成长率分析
  • 全球植入式生医材料市场表现：规模与成长，2019-2024
  • 全球植入式生医材料市场预测：2024-2029 年及 2034 年规模与成长
  • 全球植入式生医材料总目标市场（TAM）

第六章市场区隔

  • 全球植入式生医材料市场（按材料、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 金属
  • 陶瓷製品
  • 聚合物
  • 自然的
  • 全球植入式生医材料市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 牙科
  • 心血管系统
  • 眼科
  • 整形外科
  • 其他用途
  • 全球植入式生医材料市场：依最终使用者、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 全球植入式生医材料市场，依金属类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 不銹钢
  • 钛及钛合金
  • 钴铬合金
  • 全球植入式生医材料市场陶瓷细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 氧化铝
  • 羟磷石灰
  • 生物活性玻璃
  • 全球植入式生医材料市场，依聚合物类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 聚乙烯（PE）
  • 聚甲基丙烯酸甲酯（PMMA）
  • 聚乳酸（PLA）
  • 聚氨酯（PU）
  • 全球植入式生医材料市场，自然细分，依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 胶原蛋白
  • 几丁聚醣
  • 丝素蛋白

第七章 区域和国家分析

  • 全球植入式生医材料市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式生医材料市场：依国家、地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 植入式生医材料市场：竞争格局
  • 植入式生医材料市场：公司简介
    • BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • DuPont de Nemours Inc.
  • Celanese Corporation
  • Zimmer Biomet Holdings Inc.
  • Koninklijke DSM NV
  • Arthrex Inc.
  • DePuy Synthes Companies
  • Carpenter Technology Corporation
  • Corbion NV
  • GELITA AG
  • CoorsTek Inc.
  • CeramTec GmbH
  • Orthofix Holdings Inc.
  • Invibio Biomaterial Solutions plc
  • Keystone Dental Inc.
  • KLS Martin SE & Co.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年植入式生医材料市场：提供新机会的国家
  • 2029年可植入生医材料市场：细分领域带来新机会
  • 2029年植入式生医材料市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33007

Implantable biomaterials are natural or synthetic materials utilized in medical applications to support, enhance, or replace damaged tissues or biological structures.

These materials encompass metallic, ceramic, polymers, and natural substances. Metallic implants, often preferred in orthopedic prosthesis, enhance biological activities and are favored over polymeric and traditional ceramic biomaterials. They find applications in dental, cardiovascular, ophthalmology, orthopedic, and other medical fields, used across hospitals, ambulatory surgical centers, and specialty clinics.

The implantable biomaterials market research report is one of a series of new reports from The Business Research Company that provides implantable biomaterials market statistics, including implantable biomaterials industry global market size, regional shares, competitors with an implantable biomaterials market share, detailed implantable biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the implantable biomaterials industry. This implantable biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable biomaterials market size has grown rapidly in recent years. It will grow from $144.1 billion in 2024 to $165.43 billion in 2025 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to clinical success and patient outcomes, tissue engineering progress, surface modification techniques, regulatory milestones, biodegradable materials introduction.

The implantable biomaterials market size is expected to see strong growth in the next few years. It will grow to $239.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to bioactive and bioresorbable materials, smart and responsive biomaterials, regulatory and safety standards, hybrid composite materials, tissue engineering advancements. Major trends in the forecast period include drug-eluting implants, biocompatibility advancements, 3d printing and customization, regenerative medicine focus, nanotechnology integration.

Government organizations' investment in the advancement of new biomaterials, as evidenced by allocations to projects such as Drexel University's USD 200,000 grant to the National Science Foundation, is a significant driver of growth in the implantable biomaterials market. This financial support fosters research on biomaterial-mediated control over macrophage behavior, influencing biomaterial vascularization. The backing from government entities is poised to fuel further advancements in implantable biomaterials.

The increase in cardiovascular disease cases is projected to drive the growth of the implantable biomaterial market. Cardiovascular disease encompasses a range of conditions that impact the heart and blood vessels. As the incidence of cardiovascular diseases rises, so does the demand for implantable biomaterials, which are essential for the treatment and management of these conditions. These materials are utilized in various medical devices and procedures to repair or replace damaged cardiovascular tissues. With more individuals facing cardiovascular issues, the need for effective and innovative biomaterials intensifies, leading to the development of better and more efficient implants that ultimately enhance patient outcomes and quality of life. For example, a report published in October 2022 by the World Heart Federation, a Switzerland-based non-governmental organization, projects that deaths from cardiovascular diseases could increase from 22.2 million to 32.3 million by 2050. Thus, the rise in cardiovascular disease cases is expected to propel the implantable biomaterial market forward.

Major players in the implantable biomaterial market are concentrating on developing innovative products, such as the Citregen biomaterial, to improve tissue repair and regeneration outcomes. Citregen biomaterial is a biodegradable and bioresorbable synthetic material utilized in implantable devices for tissue regeneration. For example, in December 2022, Stryker Corporation, a US-based pharmaceutical company, introduced the Citrefi Suture Anchor System. This innovative Citregen biomaterial is designed to enhance bone regeneration and support the natural healing process. The sterile-packed set of the Citrefi Suture Anchor System includes a cartridge with a preloaded implant and eyelet, a drill bit, a drill guide, and a pre-assembled inserter, which streamlines the surgical process. It features a disposable suture anchor with a resorbable biomimetic anchor body, engineered to improve pull-out strength compared to traditional suture anchors while minimizing chronic inflammation during recovery. This new system is specifically designed for foot and ankle surgical procedures.

In April 2022, Integer Holdings Corporation, a U.S.-based medical device company, successfully acquired Connemara Biomedical Holdings Teoranta for an undisclosed sum. This strategic acquisition positions Integer to control implantable biomaterial technology, fostering its growth in the medical device industry. Connemara Biomedical Holdings Teoranta, based in Ireland, specializes in the manufacturing of biomaterials for cardiovascular implants.

Major companies operating in the implantable biomaterials market include BASF SE, 3M Company, Medtronic plc, Evonik Industries AG, Stryker Corporation, DuPont de Nemours Inc., Celanese Corporation, Zimmer Biomet Holdings Inc., Koninklijke DSM NV, Arthrex Inc., DePuy Synthes Companies, Carpenter Technology Corporation, Corbion NV, GELITA AG, CoorsTek Inc., CeramTec GmbH, Orthofix Holdings Inc., Invibio Biomaterial Solutions plc, Keystone Dental Inc., KLS Martin SE & Co., Collagen Matrix Inc., Cam Bioceramics BV, Aap Implantate AG, Berkeley Advanced Biomaterials Inc., AdvanSource Biomaterials Corporation, Collagen Solutions plc, Surgival SL, SBM France SAS.

North America was the largest region in the implantable biomaterials market in 2024. Western Europe was the second largest region in the global implantable biomaterials market report. The regions covered in the implantable biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable biomaterial market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Biomaterials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Material: Metallic; Ceramic; Polymers; Natural
  • 2) By Application: Dental; Cardiovascular; Ophthalmology; Orthopedic; Other Applications
  • 3) By End-user: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
  • Subsegments:
  • 1) By Metallic: Stainless Steel; Titanium And Titanium Alloys; Cobalt-Chromium Alloys
  • 2) By Ceramic: Alumina; Hydroxyapatite; Bioactive Glass
  • 3) By Polymers: Polyethylene (PE); Polymethyl Methacrylate (PMMA); Polylactic Acid (PLA); Polyurethane (PU)
  • 4) By Natural: Collagen; Chitosan; Silk Fibroin
  • Companies Mentioned: BASF SE; 3M Company; Medtronic plc; Evonik Industries AG; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Biomaterials Market Characteristics

3. Implantable Biomaterials Market Trends And Strategies

4. Implantable Biomaterials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Implantable Biomaterials Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Biomaterials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Biomaterials Market Growth Rate Analysis
  • 5.4. Global Implantable Biomaterials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Biomaterials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Biomaterials Total Addressable Market (TAM)

6. Implantable Biomaterials Market Segmentation

  • 6.1. Global Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic
  • Ceramic
  • Polymers
  • Natural
  • 6.2. Global Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dental
  • Cardiovascular
  • Ophthalmology
  • Orthopedic
  • Other Applications
  • 6.3. Global Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • 6.4. Global Implantable Biomaterials Market, Sub-Segmentation Of Metallic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stainless Steel
  • Titanium And Titanium Alloys
  • Cobalt-Chromium Alloys
  • 6.5. Global Implantable Biomaterials Market, Sub-Segmentation Of Ceramic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alumina
  • Hydroxyapatite
  • Bioactive Glass
  • 6.6. Global Implantable Biomaterials Market, Sub-Segmentation Of Polymers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polyethylene (PE)
  • Polymethyl Methacrylate (PMMA)
  • Polylactic Acid (PLA)
  • Polyurethane (PU)
  • 6.7. Global Implantable Biomaterials Market, Sub-Segmentation Of Natural, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Collagen
  • Chitosan
  • Silk Fibroin

7. Implantable Biomaterials Market Regional And Country Analysis

  • 7.1. Global Implantable Biomaterials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Biomaterials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Biomaterials Market

  • 8.1. Asia-Pacific Implantable Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Biomaterials Market

  • 9.1. China Implantable Biomaterials Market Overview
  • 9.2. China Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Biomaterials Market

  • 10.1. India Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Biomaterials Market

  • 11.1. Japan Implantable Biomaterials Market Overview
  • 11.2. Japan Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Biomaterials Market

  • 12.1. Australia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Biomaterials Market

  • 13.1. Indonesia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Biomaterials Market

  • 14.1. South Korea Implantable Biomaterials Market Overview
  • 14.2. South Korea Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Biomaterials Market

  • 15.1. Western Europe Implantable Biomaterials Market Overview
  • 15.2. Western Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Biomaterials Market

  • 16.1. UK Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Biomaterials Market

  • 17.1. Germany Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Biomaterials Market

  • 18.1. France Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Biomaterials Market

  • 19.1. Italy Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Biomaterials Market

  • 20.1. Spain Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Biomaterials Market

  • 21.1. Eastern Europe Implantable Biomaterials Market Overview
  • 21.2. Eastern Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Biomaterials Market

  • 22.1. Russia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Biomaterials Market

  • 23.1. North America Implantable Biomaterials Market Overview
  • 23.2. North America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Biomaterials Market

  • 24.1. USA Implantable Biomaterials Market Overview
  • 24.2. USA Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Biomaterials Market

  • 25.1. Canada Implantable Biomaterials Market Overview
  • 25.2. Canada Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Biomaterials Market

  • 26.1. South America Implantable Biomaterials Market Overview
  • 26.2. South America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Biomaterials Market

  • 27.1. Brazil Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Biomaterials Market

  • 28.1. Middle East Implantable Biomaterials Market Overview
  • 28.2. Middle East Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Biomaterials Market

  • 29.1. Africa Implantable Biomaterials Market Overview
  • 29.2. Africa Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Biomaterials Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Biomaterials Market Competitive Landscape
  • 30.2. Implantable Biomaterials Market Company Profiles
    • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Biomaterials Market Other Major And Innovative Companies

  • 31.1. DuPont de Nemours Inc.
  • 31.2. Celanese Corporation
  • 31.3. Zimmer Biomet Holdings Inc.
  • 31.4. Koninklijke DSM NV
  • 31.5. Arthrex Inc.
  • 31.6. DePuy Synthes Companies
  • 31.7. Carpenter Technology Corporation
  • 31.8. Corbion NV
  • 31.9. GELITA AG
  • 31.10. CoorsTek Inc.
  • 31.11. CeramTec GmbH
  • 31.12. Orthofix Holdings Inc.
  • 31.13. Invibio Biomaterial Solutions plc
  • 31.14. Keystone Dental Inc.
  • 31.15. KLS Martin SE & Co.

32. Global Implantable Biomaterials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Biomaterials Market

34. Recent Developments In The Implantable Biomaterials Market

35. Implantable Biomaterials Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Biomaterials Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Biomaterials Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Biomaterials Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer